Related Experiment Videos
Reverse transcriptase-polymerase chain reaction assays for prostate cancer
C A Olsson1, G M de Vries, R Buttyan
1Squier Urology Clinic, New York, New York, USA.
The Urologic Clinics of North America
|May 1, 1997
Summary
Reverse transcription polymerase chain reaction (RT-PCR) is a sensitive assay for detecting occult prostate cancer cells. RT-PCR positivity correlates with cancer stage and offers unique prognostic information, potentially aiding in molecular staging.
Area of Science:
- Oncology
- Molecular Diagnostics
- Biomarker Discovery
Background:
- Prostate cancer detection and staging remain critical challenges in clinical practice.
- Existing diagnostic methods may lack the sensitivity to detect minimal residual disease or micrometastases.
- The need for accurate prognostic indicators is paramount for guiding treatment decisions.
Purpose of the Study:
- To evaluate the diagnostic and prognostic utility of reverse transcription polymerase chain reaction (RT-PCR) for prostate cancer.
- To assess the ability of RT-PCR to detect occult prostate cancer cells and correlate findings with disease stage and patient outcomes.
- To explore the potential of RT-PCR for molecular staging of prostate cancer.
Main Methods:
- RT-PCR assays targeting prostate-specific markers (PSA, PSMA) were analyzed.
- Data from multiple studies combining results were reviewed for sensitivity and specificity.
- Correlation of RT-PCR positivity with prostate cancer stage, pathology reports, and treatment outcomes was examined.
- The impact of prostate manipulation on RT-PCR assay results was considered.
Main Results:
- RT-PCR demonstrated high specificity (low false-positive rate of 0.8%) and sensitivity (88% detection in metastatic patients).
- RT-PCR positivity for PSA or PSMA increased with higher prostate cancer stages.
- Preoperative negative RT-PCR predicted successful operative outcomes in 88% of cases.
- Positive RT-PCR with serum PSA >10 ng/mL indicated adverse pathology and operative failure in 90% of patients.
- RT-PCR status provided superior prognostic information compared to PSA and Gleason score in multivariate analysis.
Conclusions:
- RT-PCR is a highly sensitive and specific assay for detecting occult prostate cancer cells.
- RT-PCR assays offer valuable prognostic information and show promise for molecular staging.
- Standardization of RT-PCR techniques is crucial for widespread clinical utility.
- Further research is needed to clarify the significance of RT-PCR positivity related to prostate manipulation.